A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
Clinical trial NCT02963831 · COMPLETED
Trial details
- NCT number
- NCT02963831
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2022-06-25
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.